Main Industry
Health Care
Main Product/Service
Novel Drugs for Diabetes Treatment and Cancer Medications
The content above was translated by Ai
Founded Year
2014
Unified Business No.
24762324
Status
Closed
Number of Employees
0
Total Paid-in
Capital
- (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
VITNOVO, INC. is a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic drugs. The company's development projects all possess the advantages of addressing urgent medical needs and market opportunities. Its flagship products include novel diabetes drugs and cancer drugs that combine imaging molecules with specific cancer-targeting capabilities and highly effective chemotherapeutic drugs to establish brand-new products that are superior to original conventional drugs.
The content above was translated by Ai
